# Centrexion Therapeutics Corp — Form D

Centrexion Therapeutics Corp of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-03. The offering totals $8.8M, of which $8.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-12-03
- Form: D
- Accession: 0001592052-13-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $8.8M
- Investors: 20
- Date of first sale: 2013-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-207282

## Issuer

- Name: Centrexion Therapeutics Corp
- CIK: 0001592052
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 200 STATE STREET, BOSTON, MA, 02109
- Phone: (617) 837-6911

## Officers, directors & promoters (30)

_Showing 25 of 30 people._

| Name | Role | Location |
| --- | --- | --- |
| Michael J Ward | Executive Officer | Chevy Chase, MD |
| Sol Barer | Director | New Providence, NJ |
| Shawn R Tomasello | Director | Boston, MA |
| James N Campbell, M.D. | Director | Boston, MA |
| James N Campbell, M.D. | Executive Officer | Boston, MA |
| Sol J Barer, Ph.D. | Director | Boston, MA |
| Colin J Hill | Director | Boston, MA |
| Randall M Stevens | Executive Officer | Boston, MA |
| Joseph R Swedish | Director | Boston, MA |
| Jeffrey B Kindler | Director | Boston, MA |
| Jeffrey B Kindler | Executive Officer | Boston, MA |
| J.C. J Lopez, M.D. | Director | Boston, MA |
| J. C Lopez, M.D. | Director | BOSTON, MA |
| Peter R Wirth | Director | Boston, MA |
| Dezhi J Kang, Ph.D. | Director | BOSTON, MA |
| James N Campbell | Director | Strongsville, OH |
| James N Campbell | Executive Officer | Strongsville, OH |
| Daniel J Mendelson | Director | BOSTON, MA |
| Sara J Nayeem | Director | BOSTON, MA |
| Stella R Xu | Director | BOSTON, MA |
| Isaac Blech | Director | Jupiter, FL |
| Gregg J Beloff | Executive Officer | BOSTON, MA |
| Arnold Oronsky | Director | BOSTON, MA |
| Isaac J Blech | Director | BOSTON, MA |
| Shawn J Tomasello | Director | BOSTON, MA |

## Other filings by this issuer (16)

_Showing 15 of 16 filings._

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-01-08](https://search.stillhousedata.com/formd/0001592052-24-000003) | D | $12.9M | $3.3M |
| [2023-11-27](https://search.stillhousedata.com/formd/0001567619-23-007776) | D | $2.3M | $2.3M |
| [2023-07-11](https://search.stillhousedata.com/formd/0001567619-23-006548) | D/A | $30.0M | $10.3M |
| [2023-06-29](https://search.stillhousedata.com/formd/0001567619-23-006474) | D | $10.3M | $10.3M |
| [2022-08-11](https://search.stillhousedata.com/formd/0001567619-22-015554) | D/A | $29.1M | $29.1M |
| [2022-06-28](https://search.stillhousedata.com/formd/0001567619-22-013424) | D/A | $23.8M | $23.8M |
| [2022-06-08](https://search.stillhousedata.com/formd/0001567619-22-012509) | D | $16.5M | $16.5M |
| [2021-01-26](https://search.stillhousedata.com/formd/0001567619-21-001493) | D | $13.5M | $13.5M |
| [2018-01-02](https://search.stillhousedata.com/formd/0001140361-18-000167) | D | $69.6M | $69.6M |
| [2017-05-23](https://search.stillhousedata.com/formd/0001012975-17-000446) | D | — | $5.3M |
| [2017-01-05](https://search.stillhousedata.com/formd/0001012975-17-000014) | D | $16.6M | $16.6M |
| [2016-06-21](https://search.stillhousedata.com/formd/0001012975-16-001310) | D | — | $11.2M |
| [2016-04-15](https://search.stillhousedata.com/formd/0001012975-16-001163) | D | — | $6.9M |
| [2016-03-14](https://search.stillhousedata.com/formd/0001012975-16-001084) | D | — | $10.5M |
| [2013-12-03](https://search.stillhousedata.com/formd/0001592052-13-000003) | D/A | $35.0M | $14.7M |

## More

- [CIK 1592052 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1592052&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001592052-13-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.